These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 34842922

  • 1. Comparison of Cardiovascular Safety for Smoking Cessation Pharmacotherapies in a Population-Based Cohort in Australia.
    Havard A, Choi SKY, Pearson SA, Chow CK, Tran DT, Filion KB.
    JAMA Netw Open; 2021 Nov 01; 4(11):e2136372. PubMed ID: 34842922
    [Abstract] [Full Text] [Related]

  • 2. Smoking Cessation Pharmacotherapy Use in Pregnancy.
    Robijn AL, Tran DT, Cohen JM, Donald S, Cesta CE, Furu K, Parkin L, Pearson SA, Reutfors J, Zoega H, Zwar N, Havard A.
    JAMA Netw Open; 2024 Jun 03; 7(6):e2419245. PubMed ID: 38941092
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Use of smoking cessation pharmacotherapies during pregnancy is not associated with increased risk of adverse pregnancy outcomes: a population-based cohort study.
    Tran DT, Preen DB, Einarsdottir K, Kemp-Casey A, Randall D, Jorm LR, Choi SKY, Havard A.
    BMC Med; 2020 Feb 05; 18(1):15. PubMed ID: 32019533
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative effect of varenicline and nicotine patches on preventing repeat cardiovascular events.
    Robijn AL, Filion KB, Woodward M, Hsu B, Chow CK, Pearson SA, Jorm L, Falster MO, Havard A.
    Heart; 2023 Jun 14; 109(13):1016-1024. PubMed ID: 36878673
    [Abstract] [Full Text] [Related]

  • 7. Assessment of Racial Differences in Pharmacotherapy Efficacy for Smoking Cessation: Secondary Analysis of the EAGLES Randomized Clinical Trial.
    Nollen NL, Ahluwalia JS, Sanderson Cox L, Okuyemi K, Lawrence D, Samuels L, Benowitz NL.
    JAMA Netw Open; 2021 Jan 04; 4(1):e2032053. PubMed ID: 33464316
    [Abstract] [Full Text] [Related]

  • 8. Characterising the use of varenicline: an analysis of the Australian dispensing claims data.
    Gobarani RK, Ilomäki J, Wood S, Abramson MJ, Bonevski B, George J.
    Addiction; 2022 Oct 04; 117(10):2683-2694. PubMed ID: 35603915
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nicotine receptor partial agonists for smoking cessation.
    Cahill K, Stead LF, Lancaster T.
    Cochrane Database Syst Rev; 2012 Apr 18; (4):CD006103. PubMed ID: 22513936
    [Abstract] [Full Text] [Related]

  • 15. Treatment of Tobacco Smoking: A Review.
    Rigotti NA, Kruse GR, Livingstone-Banks J, Hartmann-Boyce J.
    JAMA; 2022 Feb 08; 327(6):566-577. PubMed ID: 35133411
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study.
    Kotz D, Viechtbauer W, Simpson C, van Schayck OC, West R, Sheikh A.
    Lancet Respir Med; 2015 Oct 08; 3(10):761-8. PubMed ID: 26355008
    [Abstract] [Full Text] [Related]

  • 17. Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study.
    Svanström H, Pasternak B, Hviid A.
    BMJ; 2012 Nov 08; 345():e7176. PubMed ID: 23138033
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study.
    Graham DJ, By K, McKean S, Mosholder A, Kornegay C, Racoosin JA, Young J, Levenson M, MaCurdy TE, Worrall C, Kelman JA.
    Pharmacoepidemiol Drug Saf; 2014 Nov 08; 23(11):1205-12. PubMed ID: 25044169
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Current pharmacologic treatments for smoking cessation and new agents undergoing clinical trials.
    Nagano T, Katsurada M, Yasuda Y, Kobayashi K, Nishimura Y.
    Ther Adv Respir Dis; 2019 Nov 08; 13():1753466619875925. PubMed ID: 31533544
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.